|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-2.39/-1.16
|
企业价值
152.10M
|
资产负债 |
每股账面净值
-4.01
|
现金流量 |
现金流量率
--
|
损益表 |
收益
--
|
每股收益
--
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/05/01 04:58 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market. |